The Iranian model, actress and scientist bonds with former NBA star over spiritual experiences with deceased loved ones during psychedelic trips.
Fungi bioscience company describes the project as “one of the most robust genetics research initiatives in the emerging psychedelics space to date.”
In this episode of the Psychedelic Spotlight podcast, we feature Jemie Sae Koo, CEO and Founder of Psychable.
July 21, 2021- This week’s Psychedelic Business News top stories…
Medavie Blue Cross partners with medical research company Braxia Scientific to cover ketamine care for veterans at Canadian Rapid Treatment Centres of Excellence.
The emerging wellness company aims to transform mental health and addiction treatments through the integration of psychedelic medicines and therapies.
Advisorshares Plant Medicine ETF will be listed on the NYSE Arca under the symbol PSIL.
And why the two-time Stanley Cup champion does not imagine working with the NHL in the “near future.”
This week in psychedelic business news: A generous donation to advance MDMA research, psilocybin for end-of-life anxiety, and provisional patents filed for synthesizing ibogaine.
Study authors even believe “treating serious mental illness may reduce adverse outcomes related to COVID-19.”
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.